Cyclacel Pharmaceuticals, Inc. Stock Agreements
9 Contracts & Agreements
- Common Stock Sales Agreement, dated October 4, 2018, by and between Cyclacel Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 4, 2018)
- [Form of Preferred Stock Certificate] (Filed With SEC on June 30, 2017)
- Cyclacel Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 23, 2016)
- Cyclacel Pharmaceuticals,Inc. Up to $8,350,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on July 13, 2015)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 14, 2013)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 17, 2012)
- AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 25, 2009)
- COMMON STOCK PURCHASE AGREEMENT by and between KINGSBRIDGE CAPITAL LIMITED and CYCLACEL PHARMACEUTICALS, INC. dated as of December 10, 2007 (Filed With SEC on December 11, 2007)
- STOCK PURCHASE AGREEMENT between: XCYTE THERAPIES, INC., a Delaware corporation; (Filed With SEC on December 20, 2005)
